Proteomic identification of plasma biomarkers in uterine leiomyoma.
about
Targeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patientsPlacenta proteome analysis from Down syndrome pregnancies for biomarker discovery.Biomarkers in uterine leiomyomaRedox- and expression-proteomic analysis of plasma biomarkers in bladder transitional cell carcinoma.Proteomic and redox-proteomic study on the role of glutathione reductase in human lung cancer cells.Quercetin-induced cardioprotection against doxorubicin cytotoxicity.Proteomic analysis of rhein-induced cyt: ER stress mediates cell death in breast cancer cells.Effect of glutathione reductase knockdown in response to UVB-induced oxidative stress in human lung adenocarcinomaPlasma Gelsolin Induced Glomerular Fibrosis via the TGF-β1/Smads Signal Transduction Pathway in IgA Nephropathy.A mass spectrometric insight into the origins of benign gynecological disorders.Hyaluronic acid-dependent protection against UVB-damaged human corneal cells.Determination of Highly Sensitive Biological Cell Model Systems to Screen BPA-Related Health Hazards Using Pathway Studio.Plasma proteomic analysis of patients infected with H1N1 influenza virus.A novel method to identify differential pathways in uterine leiomyomata based on network strategy.Proteomic analysis of prognostic plasma biomarkers in peripheral arterial occlusive disease.The value of decreased plasma gelsolin levels in patients with systemic lupus erythematosus and rheumatoid arthritis in diagnosis and disease activity evaluation.Vitamin D and Uterine Fibroids-Review of the Literature and Novel Concepts
P2860
Q28085015-630419FB-9B50-4F6E-B197-F224A74B587EQ34331621-5B8D20D0-014E-4C8C-A5CD-5759FD5D4BC3Q34406190-F1470B70-E1D7-4AE1-921B-77EC90696844Q34454754-FA0FAB1B-E63F-48BF-AC1D-9F6FA523E0FEQ35014058-325DF4B1-3339-46AE-81CE-A6D60A9D86B2Q35073746-DDF5E411-EF6C-4008-BD7D-A551E161D4B2Q35279902-358F5C6E-2696-4CD0-8F00-1DD771B3F0F7Q37528019-2175697A-9C14-42D2-8BAC-1775B9DCB682Q37690933-E74E0D2F-8B01-48B7-9D08-206FF1955D2EQ38657980-A48A303F-0B1B-4449-AE9F-E98A8E382C23Q39132756-38748010-30E4-4A38-8061-3BB928738AABQ41660919-17B77DC6-B36C-411A-928D-DE1DA5BAEEFFQ42215171-A239AE8E-4F5C-45DE-96BE-5A946435D9ACQ46002275-C8EB6DA7-CBCE-4620-9F45-2A38E3FCF904Q50988761-31FB33E2-D1D1-4C32-B264-9C7493552E63Q54766883-2A7C68BA-D3DE-4E7A-A8D8-1D3B2584FE72Q57176044-BF792531-DC8D-46A5-A53F-B7873B75E754
P2860
Proteomic identification of plasma biomarkers in uterine leiomyoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Proteomic identification of plasma biomarkers in uterine leiomyoma.
@ast
Proteomic identification of plasma biomarkers in uterine leiomyoma.
@en
Proteomic identification of plasma biomarkers in uterine leiomyoma.
@nl
type
label
Proteomic identification of plasma biomarkers in uterine leiomyoma.
@ast
Proteomic identification of plasma biomarkers in uterine leiomyoma.
@en
Proteomic identification of plasma biomarkers in uterine leiomyoma.
@nl
prefLabel
Proteomic identification of plasma biomarkers in uterine leiomyoma.
@ast
Proteomic identification of plasma biomarkers in uterine leiomyoma.
@en
Proteomic identification of plasma biomarkers in uterine leiomyoma.
@nl
P2093
P2860
P356
P1433
P1476
Proteomic identification of plasma biomarkers in uterine leiomyoma.
@en
P2093
Chao-Po Lin
Hong-Lin Chan
Hsiu-Chuan Chou
Shiou-Fen Jian
Szu-Ting Lin
Wen-Hsin Liu
Yi-Ping Chang
Yi-Wen Chen
P2860
P304
P356
10.1039/C2MB05453A
P50
P577
2011-12-22T00:00:00Z